Heron Therapeutics, Inc. (NASDAQ: HRTX) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT HERON THERAPEUTICS, INC.

Heron Therapeutics, Inc. (NASDAQ: HRTX)
Listen to this Section


$0.44
-0.0405 ( -8.38% ) 2.7M

Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.

Market Data


Open $0.44
Previous Close $0.48
Volume 2.7M
Market Cap $84.57M
Day Range $0.44 - $0.49
52 Week Range $0.43 - $2.30
Shares Outstanding 189.28M
Change % -8.38%
Net Change ▼ -0.0405
Insider Ownership -0.01%
Exchange NASDAQ
SectorMiscellaneous
IndustryNone
IPO Year1987
CountryUnited States

Insider Ownership Transactions

Total Amount Purchased: 2,110,114.00

Date Type Amount Purchased Purchaser
2024-04-05 Sale -62500.00 Collard Craig A
2024-01-19 Sale -371935.00 Duarte Ira
2024-01-19 Sale -1324502.00 Collard Craig A
2024-01-19 Sale -41078.00 Peraza Lisa
2024-01-19 Sale -371935.00 Forbes William P
2024-01-19 Sale -13948.00 Christian Waage
2024-01-19 Sale -13948.00 Rodriguez Susan
2024-01-19 Sale -13948.00 Morgan Adam
2024-01-19 Sale -13948.00 Johnson Craig A
2024-01-19 Sale -13948.00 Dissanaike Sharmila

SEC Filings


Form Type Description Pages Date
4 Insider transactions 1 Nov 12, 2025
3 Insider transactions 2 Nov 07, 2025
4 Insider transactions 1 Nov 04, 2025
8-k 8K-related 11 Nov 04, 2025
10-q Quarterly Reports 61 Nov 04, 2025
4 Insider transactions 1 Nov 04, 2025
4 Insider transactions 1 Nov 04, 2025
8-k 8K-related 11 Oct 29, 2025
4 Insider transactions 2 Oct 21, 2025
4 Insider transactions 2 Oct 21, 2025

Latest News


× Before browsing our site, please accept our cookies policy